A detailed history of Morgan Stanley transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 249,102 shares of SERA stock, worth $1.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
249,102
Previous 156,037 59.64%
Holding current value
$1.93 Million
Previous $1.42 Million 3.88%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.6 - $11.69 $521,163 - $1.09 Million
93,065 Added 59.64%
249,102 $1.47 Million
Q1 2024

Aug 16, 2024

BUY
$5.05 - $10.0 $652,712 - $1.29 Million
129,250 Added 482.51%
156,037 $1.42 Million
Q1 2024

May 15, 2024

BUY
$5.05 - $10.0 $652,712 - $1.29 Million
129,250 Added 482.51%
156,037 $1.42 Million
Q4 2023

Aug 16, 2024

SELL
$1.65 - $6.85 $366,819 - $1.52 Million
-222,315 Reduced 89.25%
26,787 $160,000
Q4 2023

Feb 13, 2024

BUY
$1.65 - $6.85 $37,567 - $155,960
22,768 Added 566.51%
26,787 $160,000
Q3 2023

Nov 15, 2023

BUY
$1.55 - $3.34 $387 - $835
250 Added 6.63%
4,019 $7,000
Q2 2023

Aug 14, 2023

SELL
$3.0 - $3.98 $5,424 - $7,195
-1,808 Reduced 32.42%
3,769 $12,000
Q1 2023

May 15, 2023

BUY
$1.19 - $4.25 $2,840 - $10,144
2,387 Added 74.83%
5,577 $21,000
Q4 2022

Feb 14, 2023

SELL
$1.16 - $1.8 $8,187 - $12,704
-7,058 Reduced 68.87%
3,190 $4,000
Q3 2022

Nov 14, 2022

BUY
$1.55 - $2.71 $1,067 - $1,867
689 Added 7.21%
10,248 $17,000
Q2 2022

Oct 27, 2022

BUY
$1.2 - $3.62 $322 - $973
269 Added 2.9%
9,559 $16,000
Q2 2022

Aug 15, 2022

BUY
$1.2 - $3.62 $322 - $973
269 Added 2.9%
9,559 $16,000
Q1 2022

Oct 27, 2022

SELL
$2.96 - $8.8 $796 - $2,367
-269 Reduced 2.81%
9,290 $35,000
Q1 2022

May 13, 2022

BUY
$2.96 - $8.8 $8,850 - $26,312
2,990 Added 47.46%
9,290 $35,000
Q4 2021

Feb 14, 2022

BUY
$6.87 - $11.41 $41,529 - $68,973
6,045 Added 2370.59%
6,300 $44,000
Q3 2021

Nov 15, 2021

BUY
$7.9 - $13.04 $2,014 - $3,325
255 New
255 $3,000

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $229M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.